We are live on ! Find out more
IART icon

Integra LifeSciences
IART

264 hedge funds and large institutions have $5.09B invested in Integra LifeSciences in 2021 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 95 increasing their positions, 77 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 29

23% more repeat investments, than reductions

Existing positions increased: 95 | Existing positions reduced: 77

3% more funds holding

Funds holding: 257 → 264 (+7)

0.95% more ownership

Funds ownership: 87.5% → 88.46% (+0.95%)

0% more capital invested

Capital invested by funds: $5.09B → $5.09B (+$4.06M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
264
Holders Change
+7
Holders Change %
+2.72%
% of All Funds
4.6%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
38
Increased
95
Reduced
77
Closed
29
Calls
$1.71M
Puts
–
Net Calls
+$1.71M
Net Calls Change
+$1.23M

Top Buyers

1
EVM
Eaton Vance Management
Massachusetts
+$14.8M
2
First Trust Advisors
First Trust Advisors
Illinois
+$12.5M
3
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$11.9M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$11.6M
5
Macquarie Group
Macquarie Group
Australia
+$11.4M

Top Sellers

1
Invesco
Invesco
Georgia
-$17.9M
2
Millennium Management
Millennium Management
New York
-$14.3M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$7.63M
4
MPAM
Monarch Partners Asset Management
Massachusetts
-$5.71M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$5.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
IPW
226
IronBridge Private Wealth
Texas
$13K – – –
QCG
227
Quadrant Capital Group
Ohio
$13K +$849 +12 +7%
RE
228
RBC Europe
United Kingdom
$12.1K +$12.6K +178 New
KFP
229
KB Financial Partners
New Jersey
$12K -$3.04K -43 -20%
ST
230
Sageworth Trust
Pennsylvania
$12K +$12.7K +180 New
BCA
231
Berman Capital Advisors
Georgia
$11K – – –
LC
232
Lindbrook Capital
California
$11K – – –
IA
233
IFP Advisors
Florida
$10K – – –
HI
234
Harbour Investments
Wisconsin
$10K +$566 +8 +6%
PCG
235
Private Capital Group
Connecticut
$9K -$919 -13 -9%
S
236
SignatureFD
Georgia
$9K +$495 +7 +6%
AIG
237
American International Group
New York
$8.61K -$160K -2,259 -2%
CAGAS
238
Capital Advisory Group Advisory Services
Minnesota
$8K – – –
ST
239
Smithfield Trust
Pennsylvania
$8K – – –
Northwestern Mutual Wealth Management
240
Northwestern Mutual Wealth Management
Wisconsin
$8K +$8.2K +116 New
FRA
241
Front Row Advisors
California
$6K – – –
GAM
242
Gemmer Asset Management
California
$6K – – –
BWM
243
BerganKDV Wealth Management
Minnesota
$5K – – –
TWA
244
TCI Wealth Advisors
Arizona
$5K – – –
HR
245
Howe & Rusling
New York
$3K -$778 -11 -18%
Carson Wealth (CWM LLC)
246
Carson Wealth (CWM LLC)
Nebraska
$3K – – –
FPS
247
Fieldpoint Private Securities
Connecticut
$3K – – –
PA
248
Parallel Advisors
California
$3K – – –
GFPC
249
Global Financial Private Client
Florida
$2.63K – – –
HPC
250
HM Payson & Co
Maine
$2K – – –
8 9
10
11 12

IART Hedge Fund Activity: Q2 2021 in Review

264 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q2 2021, worth a combined $5.09B — up 0.08% from $5.09B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new IART positions and 29 closed out — a net gain of 9 holders — while 95 added to existing stakes and 77 trimmed.

The largest buyer was Eaton Vance Management, adding an estimated $14.8M. The largest seller was Invesco, cutting an estimated $17.9M.

  • 264 institutional investors held Integra LifeSciences (IART) as of Q2 2021, up from 257 in Q1 2021.
  • Funds reported $5.09B of Integra LifeSciences stock for Q2 2021, up 0.08% quarter-over-quarter.
  • 38 funds opened new Integra LifeSciences positions in Q2 2021 and 29 closed out, a net change of +9 holders.
  • The largest Integra LifeSciences buyer in Q2 2021 was Eaton Vance Management, an estimated $14.8M added.
  • The largest Integra LifeSciences seller in Q2 2021 was Invesco, an estimated $17.9M sold.

Based on aggregated 13F filings for Q2 2021.